Online citations, reference lists, and bibliographies.
← Back to Search

Albumin-stabilized Epirubicin Nanocarriers Of Core–shell Type Based On Poly(butyl Cyanoacrylate) And Poly(styrene-co-maleic Acid)

Nadezhda Angelova, G. Yordanov
Published 2015 · Chemistry

Cite This
Download PDF
Analyze on Scholarcy
Abstract This article describes a facile approach for preparation of novel albumin-stabilized polymer nanoparticles of core–shell type based on poly(butyl cyanoacrylate) (PBCA) and poly(styrene-co-maleic acid) (PSMA) as carriers for the anticancer drug epirubicin. The PBCA/PSMA particles were obtained by nanoprecipitation and were found to be spherical in shape, with monomodal size distribution and negative zeta-potentials. Particles of increasing average sizes between 100 and 200 nm were prepared by increasing the PBCA/PSMA ratio. Even 5 wt% of PSMA in the PBCA/PSMA particles resulted in increased electrostatic stabilization of the drug-free colloids and larger absolute value of the zeta potential. This effect on the electrokinetic behavior was attributed to enhanced deposition of the amphiphilic PSMA component at the particle surface and formation of a PSMA-enriched shell over the PBCA-enriched particle core. Epirubicin was loaded to the PBCA/PSMA particles by sorption. Only 5 wt% of PSMA in the PBCA/PSMA particles was enough to increase drug loading efficiency to ∼95% and to improve albumin adsorption on the particle surface leading to increased colloidal stability. The obtained albumin-stabilized PBCA/PSMA epirubicin carriers did not cause any significant hemolysis (tested in vitro), neither affected the osmotic fragility of erythrocytes, which is an important prerequisite for biomedical applications.
This paper references
Time-dependent changes in opsonin amount associated on nanoparticles alter their hepatic uptake characteristics.
Susumu Nagayama (2007)
Nanoparticles in cellular drug delivery.
A. H. Faraji (2009)
Stimuli-responsive nanocarriers for drug delivery.
S. Mura (2013)
Preparation of poly(butylcyanoacrylate) drug carriers by nanoprecipitation using a pre-synthesized polymer and different colloidal stabilizers
G. Yordanov (2010)
Nanocarriers’ entry into the cell: relevance to drug delivery
H. Hillaireau (2009)
SMA-doxorubicin, a new polymeric micellar drug for effective targeting to solid tumours.
K. Greish (2004)
Opsonization, Biodistribution, Cellular Uptake and Apoptosis Study of PEGylated PBCA Nanoparticle as Potential Drug Delivery Carrier
K. Chaudhari (2011)
Protein Binding of Macromolecular Anticancer Agent SMANCS: Characterization of Poly(styrene-co-maleic acid) Derivatives as an Albumin Binding Ligand
A. Kobayashi (1988)
Tumor delivery of macromolecular drugs based on the EPR effect.
V. Torchilin (2011)
Nanoparticles--a historical perspective.
J. Kreuter (2007)
Epirubicin loading in poly(butyl cyanoacrylate) nanoparticles manifests via altered intracellular localization and cellular response in cervical carcinoma (HeLa) cells
Aleksandar Evangelatov (2016)
Styrene Maleic Acid-Pirarubicin Disrupts Tumor Microcirculation and Enhances the Permeability of Colorectal Liver Metastases
J. Daruwalla (2008)
Nanomedicine and personalized medicine toward the application of pharmacotyping in clinical practice to improve drug-delivery outcomes.
I. Vizirianakis (2011)
Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles.
Donald E. Owens (2006)
The EPR effect: Unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect.
J. Fang (2011)
Synthesis of poly(alkyl cyanoacrylate)-based colloidal nanomedicines.
J. Nicolas (2009)
Surface-modified biodegradable albumin nano- and microspheres. II: effect of surface charges on in vitro phagocytosis and biodistribution in rats.
M. Roser (1998)
Copoly(styrene-maleic acid)-pirarubicin micelles: high tumor-targeting efficiency with little toxicity.
K. Greish (2005)
Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacy.
P. Aggarwal (2009)
Nanosystem drug targeting: Facing up to complex realities.
Pakatip Ruenraroengsak (2010)
Poly(alkylcyanoacrylates) as biodegradable materials for biomedical applications.
C. Vauthier (2003)
Nanoparticles of poly(styrene-co-maleic acid) as colloidal carriers for the anticancer drug epirubicin
Nadezhda Angelova (2014)
A computationally derived structural model of doxorubicin interacting with oligomeric polyalkylcyanoacrylate in nanoparticles.
J. Poupaert (2003)
Adsorbed proteins influence the biological activity and molecular targeting of nanomaterials.
Debamitra Dutta (2007)
Albumin as a drug carrier: design of prodrugs, drug conjugates and nanoparticles.
F. Kratz (2008)
Visualization of in vitro protein-rejecting properties of PEGylated stealth polycyanoacrylate nanoparticles.
M. Peracchia (1999)
Mechanism of tumor-targeted delivery of macromolecular drugs, including the EPR effect in solid tumor and clinical overview of the prototype polymeric drug SMANCS.
H. Maeda (2001)
Macromolecular therapeutics in cancer treatment: the EPR effect and beyond.
H. Maeda (2012)
Preparation and characterization of carbonyl iron/poly(butylcyanoacrylate) core/shell nanoparticles.
J. L. Arias (2006)

This paper is referenced by
Semantic Scholar Logo Some data provided by SemanticScholar